The group developed a PEGylated lipid-based nanoparticle named LNPK15 using two novel cationic lipids, SST-01 and SST-31, encapsulating KRAS siRNA that showed long circulation and efficient siRNA delivery to tumor sites. This evidence concerns the gene KRAS and neoplasm.